Document is current
Any future updates will be listed below
-
Authors
Cash, Alan https://orcid.org/0000-0003-1916-960X
Kaufman, David Lyons
-
Funding
Funding for this research was provided by:
Terra Biological LLC
- License Information
-
More Information
Article History
Received: 20 May 2022
Accepted: 15 June 2022
First Online: 28 June 2022
Change Date: 3 October 2023
Change Type: Clarification
Change Details: Editors' Note: Readers are advised that concerns have been raised regarding the methodology and reporting of this clinical trial and an incomplete declaration of competing interests, which are currently being investigated by the Editor-in-Chief. Further editorial action will be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.
Declarations
:
: The Post COVID-Fatigue trial and the ME/CFS trial were both reviewed and approved by Institute of Regenerative and Cellular Medicine, an Institutional Review Board. IRCM-2020–263, IRCM-2020.
: Not applicable.
: Author David Kaufman has no competing interests. Author Alan Cash is an officer in a pharmaceutical company that provided the funding for this clinical trial. Funding was provided by Terra Biological LLC.
